Party drug use in techno nights: A field survey among French-speaking Swiss attendees

Pharmacology Biochemistry and Behavior

Volumn 86, Issue 2, 2007, Pages 284-289

  Chinet, Léonie ^a   Stéphan, Philippe ^a   Zobel, Frank ^b   Halfon, Olivier ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Access to health care; Adolescents; Cocaine; Dancing; Drug use; Harm reduction; MDMA; Prevention; Problem use; Young adults

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; CANNABIS;

ADOLESCENT; ADULT; ANXIETY; ARTICLE; ATTITUDE TO HEALTH; CONTROLLED STUDY; DANCING; DEPRESSION; DRUG ABUSE PATTERN; EMERGENCY TREATMENT; FEMALE; GENDER; GENERAL PRACTITIONER; HARM REDUCTION; HEALTH CARE ACCESS; HEALTH CARE PLANNING; HEALTH SURVEY; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MUSIC; PATIENT COUNSELING; PRIORITY JOURNAL; RECREATION; SLEEP DISORDER; SOCIAL PROBLEM; SUBSTANCE ABUSE; SWITZERLAND; TOOTH DISEASE;

ADOLESCENT; ADULT; ALCOHOL DRINKING; COUNSELING; DANCING; EAR PROTECTIVE DEVICES; EMERGENCY MEDICAL SERVICES; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MIDDLE AGED; MUSIC; SUBSTANCE-RELATED DISORDERS; SWITZERLAND; WATER;

CANNABIS;

EID: 33847132829     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2006.07.025     Document Type: Article

References (27)

1. Brookhuis K.A., de Waard D., and Samyn N. Effects of MDMA (ecstasy), and multiple drugs use on (simulated) driving performance and traffic safety. Psychopharmacology 173 3-4 (2004) 440-445 [References]
2. Copeland J., Dillon P., and Gascoigne M. Ecstasy and the concomitant use of pharmaceuticals. Addict Behav 31 2 (2006) 367-370
3. Council Decision. Council decision on the information exchange, risk-assessment and control of new psychoactive substances. Official Journal L vol. 127 (2005) 0032-0037
4. EMCDDA. Annual report 2005: the state of the drugs problem in Europe (2005), Office for Official Publications of the European Communities, Luxembourg
5. Feldman N., and Croquette-Krokar M. The new drugs: ecstasy, GHB. Update for practitioners. Rev Med Suisse Romande 121 12 (2001) 885-888
6. Fendrich M., Wislar J.S., Johnson T.P., and Hubbell A. A contextual profile of club drug use among adults in Chicago. Addiction 98 12 (2003) 1693-1703
7. Gamma A., Jerome L., Liechti M.E., and Sumnall H.R. Is ecstasy perceived to be safe? A critical survey. Drug Alcohol Depend 77 2 (2005) 185-193
8. ISPA. Chiffres et données 2003. CD-rom. In. Lausanne: ISPA, 2003.
9. Khong E., and Wain T. The growing challenge of party drugs in general practice. Aust Fam Physician 33 9 (2004) 709-713
10. McCambridge J., and Strang J. The efficacy of single-session motivational interviewing in reducing drug consumption and perceptions of drug-related risk and harm among young people: results from a multi-site cluster randomized trial. Addiction 99 1 (2004) 39-52
11. McCambridge J., and Strang J. Deterioration over time in effect of motivational interviewing in reducing drug consumption and related risk among young people. Addiction 100 4 (2005) 470-478
12. McCambridge J., Mitcheson L., Winstock A., and Hunt N. Five-year trends in patterns of drug use among people who use stimulants in dance contexts in the United Kingdom. Addiction 100 8 (2005) 1140-1149
13. McElrath K., and McEvoy K. Negative experiences on ecstasy: the role of drug, set and setting. J Psychoact Drugs 34 2 (2002) 199-208
14. Narring F., Tschumper A., Inderwildi Bonivento L., Jeannin A., Addor V., Bütikofer A., et al. Santé et styles de vie des adolescents âgés de 16 à 20 ans en Suisse (2002). SMASH 2002: Swiss Multicenter Adolescent Study on Health 2002 (2004), Institut Universitaire de Médecine Sociale et Préventive, Lausanne
15. Parrott A.C. Human psychopharmacology of ecstasy (MDMA). A review of 15 years of empirical research. Hum Psychopharmacol 16 8 (2001) 557-577
16. Parrott A.C. MDMA (3,4-methylenedioxymethamphetamine) or ecstasy: the neuropsychobiological implications of taking it at dances and raves. Neuropsychobiology 50 4 (2004) 329-335
17. Parrott A.C., Buchanan T., Scholey A.B., Heffernan T., Ling J., and Rodgers J. Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users. Hum Psychopharmacol 17 6 (2002) 309-312
18. Pedersen W., and Skrondal A. Ecstasy and new patterns of drug use: a normal population study. Addiction 94 11 (1999) 1695-1706
19. Ricaurte G.A., and McCann U.D. Recognition and management of complications of new recreational drug use. Lancet 365 9477 (2005) 2137-2145
20. Riley S.C., James C., Gregory D., Dingle H., and Cadger M. Patterns of recreational drug use at dance events in Edinburgh, Scotland. Addiction 96 7 (2001) 1035-1047
21. Samitca S., Arnaud S., Zobel F., and Dubois-Arber F. Usage de drogues de synthèse et de cocaïne en milieu festif: état des lieux dans le canton de Vaud (2005), IUMSP (Institut universitaire de médecine sociale et préventive), Lausanne
22. Solowij N., Hall W., and Lee N. Recreational MDMA use in Sydney: a profile of 'ecstacy' users and their experiences with the drug. Br J Addict 87 8 (1992) 1161-1172
23. The Council of the EU. EU drugs strategy 2005-2012 (2004), The Concil of the EU, Brussels 1-20
24. Tossmann P., Boldt S., and Tensil M.D. The use of drugs within the techno party scene in European metropolitan cities. Eur Addict Res 7 1 (2001) 2-23
25. White B., Degenhardt L., Breen C., Bruno R., Newman J., and Proudfoot P. Risk and benefit perceptions of party drug use. Addict Behav 31 1 (2006) 137-142
26. Winstock A.R., Wolff K., and Ramsey J. Ecstacy pill testing: harm minimization gone too far?. Addiction 96 8 (2001) 1139-1148
27. Zobel F., and Arnaud S. Un système d'alerte pour les drogues illégales: développement de scénarios (2002), IUMSP (Institut universitaire de médecine sociale et préventive), Lausanne